Phase 1b study of pegylated arginine deiminase (ADI-PEG 20) plus Pembrolizumab in advanced solid cancers

OncoImmunology ◽

10.1080/2162402x.2021.1943253 ◽

2021 ◽

Vol 10 (1) ◽

pp. 1943253

Author(s):

Kwang-Yu Chang ◽

Nai-Jung Chiang ◽

Shang-Yin Wu ◽

Chia-Jui Yen ◽

Shang-Hung Chen ◽

...

Keyword(s):

Arginine Deiminase ◽

Download Full-text

Abstract #796012: Phase 1B Evaluation of the Pharmacokinetics and Pharmacodynamics of Abaloparatide Solid Microstructured Transdermal System in Postmenopausal Women with Low Bone Mineral Density

Endocrine Practice ◽

10.1016/s1530-891x(20)39452-0 ◽

2020 ◽

Vol 26 ◽

pp. 44-45

Author(s):

Joanna Rega

Keyword(s):

Bone Mineral Density ◽

Postmenopausal Women ◽

Bone Mineral ◽

Pharmacokinetics And Pharmacodynamics ◽

Mineral Density ◽

Low Bone Mineral Density ◽

Download Full-text

Recombinant Forms of Arginase and Arginine Deiminase as Catalytic Components of «Argitest» Enzymatic Kit for L-arginine Analysis

Science and innovation ◽

10.15407/scine13.04.056 ◽

2017 ◽

Vol 13 (4) ◽

pp. 56-63 ◽

Author(s):

N.Ye. Stasiuk ◽

◽

G.Z. Gaida ◽

A.Ye. Zakalskiy ◽

O.M. Zakalska ◽

...

Keyword(s):

Arginine Deiminase

Download Full-text

Phase 1B Study of KSP/QRH Dimer for Detection of Neoplasia in the Esophagus

Case Medical Research ◽

10.31525/ct1-nct03852576 ◽

2019 ◽

Author(s):

Keyword(s):

Download Full-text

A Parallel Arm Phase 1b/2a Study of DKN-01 as Monotherapy or in Combination With Docetaxel for the Treatment of Advanced Prostate Cancer With Elevated DKK1

Case Medical Research ◽

10.31525/ct1-nct03837353 ◽

2000 ◽

Author(s):

Keyword(s):

Prostate Cancer ◽

Advanced Prostate Cancer ◽

Download Full-text

Orphan designation: Pegylated recombinant arginine deiminase, Treatment of malignant mesothelioma

Case Medical Research ◽

10.31525/cmr-ea7c32 ◽

2019 ◽

Author(s):

Keyword(s):

Malignant Mesothelioma ◽

Arginine Deiminase ◽

Orphan Designation

Download Full-text

Orphan designation: Pegylated recombinant arginine deiminase, Treatment of malignant mesothelioma

Case Medical Research ◽

10.31525/cmr-ea2d1f ◽

2019 ◽

Author(s):

Keyword(s):

Malignant Mesothelioma ◽

Arginine Deiminase ◽

Orphan Designation

Download Full-text

A Phase 1b Master Trial to Investigate CPX-351 in Subjects With Previously Untreated Acute Myeloid Leukemia

Case Medical Research ◽

10.31525/ct1-nct04075747 ◽

2019 ◽

Author(s):

Keyword(s):

Acute Myeloid Leukemia ◽

Myeloid Leukemia ◽

Phase 1B ◽

Download Full-text

An Open-Label, Multicenter, Phase 1b/2 Study of the Safety and Efficacy of KRT-232 Combined With Low-Dose Cytarabine (LDAC) or Decitabine in Patients With Acute Myeloid Leukemia (AML)

Case Medical Research ◽

10.31525/ct1-nct04113616 ◽

2019 ◽

Author(s):

Keyword(s):

Acute Myeloid Leukemia ◽

Myeloid Leukemia ◽

Low Dose ◽

Safety And Efficacy ◽

Multicenter Phase ◽

Phase 1B ◽

Low Dose Cytarabine ◽

Download Full-text

Faculty Opinions recommendation of A fluoroacetamidine-based inactivator of protein arginine deiminase 4: design, synthesis, and in vitro and in vivo evaluation.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1031506.367705 ◽

2006 ◽

Author(s):

Karen Allen

Keyword(s):

Arginine Deiminase ◽

In Vivo Evaluation ◽

Design Synthesis ◽

Protein Arginine Deiminase

Download Full-text

Faculty Opinions recommendation of Combination of ibrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) for treatment-naive patients with CD20-positive B-cell non-Hodgkin lymphoma: a non-randomised, phase 1b study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718499066.793521333 ◽

2016 ◽

Author(s):

Won Seog Kim

Keyword(s):

B Cell ◽

Hodgkin Lymphoma ◽

Non Hodgkin Lymphoma ◽

Treatment Naïve ◽

Download Full-text